T2DM is an obesity-related metabolic syndrome with the sustained activation of the NLRP3 inflammasome, which is a critical component of the innate immune system mediating caspase-1 activation and the secretion of proinflammatory cytokines IL-1β/IL-18. This evidence concerns the gene NLRP3 and obesity disorder.